Cargando…
Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms
OBJECTIVE: The present study analyzed whether renally eliminated antibiotics achieve sufficient urinary concentrations based on their pharmacokinetic/pharmacodynamic principles to effectively eradicate organisms deemed resistant by automated susceptibility testing. RESULTS: Lower median minimum inhi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053836/ https://www.ncbi.nlm.nih.gov/pubmed/30029611 http://dx.doi.org/10.1186/s13104-018-3599-8 |
_version_ | 1783340903319994368 |
---|---|
author | Chastain, Daniel B. King, S. Travis Stover, Kayla R. |
author_facet | Chastain, Daniel B. King, S. Travis Stover, Kayla R. |
author_sort | Chastain, Daniel B. |
collection | PubMed |
description | OBJECTIVE: The present study analyzed whether renally eliminated antibiotics achieve sufficient urinary concentrations based on their pharmacokinetic/pharmacodynamic principles to effectively eradicate organisms deemed resistant by automated susceptibility testing. RESULTS: Lower median minimum inhibitory concentrations against enterobacteriaceae were noted for ceftriaxone, cefepime, and doripenem when comparing Etest(®) to Vitek(®). All Pseudomonas aeruginosa isolates were susceptible to cefepime, ciprofloxacin, and doripenem with both susceptibility methods, but higher median minimum inhibitory concentrations were observed with Etest(®). Urine concentrations/time profiles were calculated for standard doses of ceftriaxone, cefepime, doripenem, and ciprofloxacin. The data presented in the current study suggests high urine concentrations of antibiotics may effectively eradicate bacteria which were determined to be resistant per in vitro susceptibility testing. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13104-018-3599-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6053836 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60538362018-07-23 Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms Chastain, Daniel B. King, S. Travis Stover, Kayla R. BMC Res Notes Research Note OBJECTIVE: The present study analyzed whether renally eliminated antibiotics achieve sufficient urinary concentrations based on their pharmacokinetic/pharmacodynamic principles to effectively eradicate organisms deemed resistant by automated susceptibility testing. RESULTS: Lower median minimum inhibitory concentrations against enterobacteriaceae were noted for ceftriaxone, cefepime, and doripenem when comparing Etest(®) to Vitek(®). All Pseudomonas aeruginosa isolates were susceptible to cefepime, ciprofloxacin, and doripenem with both susceptibility methods, but higher median minimum inhibitory concentrations were observed with Etest(®). Urine concentrations/time profiles were calculated for standard doses of ceftriaxone, cefepime, doripenem, and ciprofloxacin. The data presented in the current study suggests high urine concentrations of antibiotics may effectively eradicate bacteria which were determined to be resistant per in vitro susceptibility testing. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13104-018-3599-8) contains supplementary material, which is available to authorized users. BioMed Central 2018-07-20 /pmc/articles/PMC6053836/ /pubmed/30029611 http://dx.doi.org/10.1186/s13104-018-3599-8 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Note Chastain, Daniel B. King, S. Travis Stover, Kayla R. Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms |
title | Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms |
title_full | Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms |
title_fullStr | Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms |
title_full_unstemmed | Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms |
title_short | Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms |
title_sort | rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms |
topic | Research Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053836/ https://www.ncbi.nlm.nih.gov/pubmed/30029611 http://dx.doi.org/10.1186/s13104-018-3599-8 |
work_keys_str_mv | AT chastaindanielb rethinkingurinaryantibioticbreakpointsanalysisofurinaryantibioticconcentrationstotreatmultidrugresistantorganisms AT kingstravis rethinkingurinaryantibioticbreakpointsanalysisofurinaryantibioticconcentrationstotreatmultidrugresistantorganisms AT stoverkaylar rethinkingurinaryantibioticbreakpointsanalysisofurinaryantibioticconcentrationstotreatmultidrugresistantorganisms |